Company intelligence / Profile preview

Liaoning Chengda Biotechnology Co., Ltd.

Shenyang, Liaoning, Chinaen.chengda.com.cn ↗
Ownership
Private
Employees
~1732
Development stage
Commercial
01

Overview

The company has two approved vaccines in the market: Rabies Vaccine for Human Use (SPEEDA®) and Inactivated Japanese Encephalitis Vaccine (JEVAC®). The rabies vaccine has been sold in more than 30 countries with 400 million doses without any immunization failure. Several other vaccines are in various stages of development, including a Tetravalent influenza vaccine at NDA/BLA stage, a Recombinant Fifteen Valent Human Papillomavirus Vaccine in Phase 2, and a Haemophilus Influenzae Type b Conjugate Vaccine in Phase 1.

Therapeutic areas
Infectious Diseases
Modalities
Vaccines (Prophylactic vaccinesCombination vaccinesConjugated vaccinesMultivalent vaccinesLive attenuated vaccinesRecombinant protein vaccines)
Industry
Biotech
02

Drug pipeline

7 assets

japanese encephalitis vaccine (vero cell), inactivated

4

6 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Liaoning Chengda Biotechnology Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liaoning Chengda Biotechnology Co., Ltd..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call